APA (7th ed.) Citation

WJ, V., JM, B., AJ, P., M, B., V, F., R, W., . . . Group, P. S. (2007). PROactive 06: Cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Diabetic Medicine, 24(9), 982. https://doi.org/10.1111/j.1464-5491.2007.02188.x

Chicago Style (17th ed.) Citation

WJ, Valentine, et al. "PROactive 06: Cost-effectiveness of Pioglitazone in Type 2 Diabetes in the UK." Diabetic Medicine 24, no. 9 (2007): 982. https://doi.org/10.1111/j.1464-5491.2007.02188.x.

MLA (9th ed.) Citation

WJ, Valentine, et al. "PROactive 06: Cost-effectiveness of Pioglitazone in Type 2 Diabetes in the UK." Diabetic Medicine, vol. 24, no. 9, 2007, p. 982, https://doi.org/10.1111/j.1464-5491.2007.02188.x.